These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 8662680

  • 1. The role of passive transbilayer drug movement in multidrug resistance and its modulation.
    Eytan GD, Regev R, Oren G, Assaraf YG.
    J Biol Chem; 1996 May 31; 271(22):12897-902. PubMed ID: 8662680
    [Abstract] [Full Text] [Related]

  • 2. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R, Katzir H, Yeheskely-Hayon D, Eytan GD.
    FEBS J; 2007 Dec 31; 274(23):6204-14. PubMed ID: 17986257
    [Abstract] [Full Text] [Related]

  • 3. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.
    Eytan GD, Regev R, Oren G, Hurwitz CD, Assaraf YG.
    Eur J Biochem; 1997 Aug 15; 248(1):104-12. PubMed ID: 9310367
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of action of P-glycoprotein in relation to passive membrane permeation.
    Eytan GD, Kuchel PW.
    Int Rev Cytol; 1999 Aug 15; 190():175-250. PubMed ID: 10331240
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123.
    Koizumi S, Konishi M, Ichihara T, Wada H, Matsukawa H, Goi K, Mizutani S.
    Eur J Cancer; 1995 Sep 15; 31A(10):1682-8. PubMed ID: 7488425
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.
    Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN.
    Biochem Pharmacol; 2002 Aug 15; 64(4):573-82. PubMed ID: 12167476
    [Abstract] [Full Text] [Related]

  • 10. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U, Lage H, Jordan A, Walther W, Bates SE, Litman T, Hohenberger P, Dietel M.
    Int J Cancer; 2002 Feb 20; 97(6):751-60. PubMed ID: 11857350
    [Abstract] [Full Text] [Related]

  • 11. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
    Sikic BI, Fisher GA, Lum BL, Halsey J, Beketic-Oreskovic L, Chen G.
    Cancer Chemother Pharmacol; 1997 Feb 20; 40 Suppl():S13-9. PubMed ID: 9272128
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp).
    Jansson PJ, Yamagishi T, Arvind A, Seebacher N, Gutierrez E, Stacy A, Maleki S, Sharp D, Sahni S, Richardson DR.
    J Biol Chem; 2015 Apr 10; 290(15):9588-603. PubMed ID: 25720491
    [Abstract] [Full Text] [Related]

  • 14. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
    Barrand MA, Bagrij T, Neo SY.
    Gen Pharmacol; 1997 May 10; 28(5):639-45. PubMed ID: 9184795
    [Abstract] [Full Text] [Related]

  • 15. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P, Chearwae W, Shukla S, Phisalphong C, Ambudkar SV.
    Mol Cell Biochem; 2007 Feb 10; 296(1-2):85-95. PubMed ID: 16960658
    [Abstract] [Full Text] [Related]

  • 16. Changes in intra- or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance.
    Altenberg GA, Young G, Horton JK, Glass D, Belli JA, Reuss L.
    Proc Natl Acad Sci U S A; 1993 Oct 15; 90(20):9735-8. PubMed ID: 8105483
    [Abstract] [Full Text] [Related]

  • 17. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.
    Borgnia MJ, Eytan GD, Assaraf YG.
    J Biol Chem; 1996 Feb 09; 271(6):3163-71. PubMed ID: 8621716
    [Abstract] [Full Text] [Related]

  • 18. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
    Ramachandra M, Ambudkar SV, Gottesman MM, Pastan I, Hrycyna CA.
    Mol Biol Cell; 1996 Oct 09; 7(10):1485-98. PubMed ID: 8898356
    [Abstract] [Full Text] [Related]

  • 19. Relationships between rhodamine 123 transport, cell volume, and ion-channel function of P-glycoprotein.
    Altenberg GA, Vanoye CG, Han ES, Deitmer JW, Reuss L.
    J Biol Chem; 1994 Mar 11; 269(10):7145-9. PubMed ID: 7510282
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO, Aksentijevich I, Pastan I, Gottesman MM.
    Cancer Res; 1995 Mar 01; 55(5):1086-91. PubMed ID: 7866993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.